Related Experiment Videos

Antibiotic treatment of infectious peritonitis in chronic peritoneal dialysis

Insights

Antibiotic therapy effectively treats infectious peritonitis in patients on peritoneal dialysis, with a 90% success rate for continuing dialysis. Shorter treatment durations increased relapse risk.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Internal Medicine

Background:

  • Peritonitis is a significant complication for patients undergoing chronic intermittent peritoneal dialysis.
  • Effective antibiotic management is crucial for successful peritonitis treatment and dialysis continuation.

Purpose of the Study:

  • To evaluate the efficacy and outcomes of antibiotic treatment for infectious peritonitis in peritoneal dialysis patients.
  • To assess factors influencing the continuation of peritoneal dialysis after peritonitis treatment.

Main Methods:

  • Retrospective analysis of 97 primary peritonitis episodes in 66 patients on chronic intermittent peritoneal dialysis over 3 years.
  • Evaluation of antibiotic toxicity, treatment duration, relapse rates, superinfections, catheter replacement, and mortality.

Main Results:

  • 87% of cases treated with low-toxicity antibiotics; 90% overall continuation rate of peritoneal dialysis.
  • Relapse occurred in 10% (associated with <2 weeks treatment), superinfection in 5%, catheter replacement in 15%.
  • Mortality was 4%, linked to severe underlying conditions or complications.

Conclusions:

  • Antibiotic treatment is highly effective for infectious peritonitis in peritoneal dialysis patients, enabling high rates of dialysis continuation.
  • Adequate treatment duration (≥2 weeks) appears crucial to prevent relapse.
  • While generally safe, antibiotic side effects and technical dialysis issues require monitoring.

Related Concept Videos